These important observations not only support previous findings that Cyclin D1 and Bcl-2 are target genes silenced by miR-195 but also demonstrate that the expression of miR-195 is potentially a more accurate prognostic tumor marker than Cyclin D1 or Bcl-2 levels alone in TSCC patients. Here, BCL2 is linked to neoplasm.